Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.04

€4.04

-4.740%
-0.38
-4.740%
€13.50

€13.50

 
06.05.21 / Tradegate WKN: A2N7N2 / Symbol: ARAV / Name: Aravive / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
-
01.10.20
€13.50
16.02.20
buy
Your prediction

Aravive, Inc. Stock

Heavy losses for Aravive, Inc. today as the stock fell by -€0.380 (-4.740%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Aravive, Inc. stock is not clear.
Based on the current price of €4.04 the target price of €13.00 shows a potential of 221.782% for Aravive, Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Aravive, Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Aravive, Inc. in the next few years

Pros
1
Could be worthwhile Investment >10% per year
Cons
0
-

Performance of Aravive, Inc. vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Aravive, Inc. -4.740% -7.339% -12.174% -62.936% -24.486% - -
Corvus Pharmaceuticals Inc -3.310% 2.632% -3.306% -25.000% -22.517% -71.463% -78.259%
Epizyme Inc. 21.420% 4.868% -3.624% -57.450% -29.451% - -
Glycomimetics Inc. -2.600% -6.500% -22.727% -32.246% -40.823% - -

Other discussions about Aravive, Inc. Stock

New thread Forum